Phacilitate Leaders World

Conference speakers

Conference speakers

Loading
  • Letter
    • G
  • Tim Ganey

    Dr Tim Ganey

    Director / Director of Orthopaedic Research / Chief Scientific Officer, Atlanta Teaching and Learning Center / Atlanta Medical Center / Vivex Biomedical
  • Dan Gincel

    Dr Dan Gincel

    Vice President for University Partnerships / Executive Director, Maryland Technology Development Corporation (TEDCO) / Maryland Stem Cell Research Fund
  • Ted Goldberg

    Ted Goldberg

    Founder & CEO, Cordon Vital
  • Steve Goodman

    Steve Goodman

    Head of Drug Product Manufacturing, bluebird bio
  • Asthika Goonewardene

    Dr Asthika Goonewardene

    Senior Biotech Analyst, Bloomberg Intelligence
  • Gayle Gordillo

    Dr Gayle Gordillo

    Vice President of Research / Chief of Plastic Surgery, American Society of Plastic Surgeons / Indiana University School of Medicine
  • Philip Gotwals

    Philip Gotwals

    Head, Search and Evaluation, Strategic Alliances, Novartis Institute BioMedical Research (NIBR)
  • Rachel Griffiths

    Rachel Griffiths

    Associate Director, Technical Services, PCI Clinical Services
  • Nicole Gularte

    Nicole Gularte

    Patient Advocate, Fight for Cures
  • Christine Günther

    Christine Günther

    CEO, apceth Biopharma GmbH
Testimonials
  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Anne-Virginie Eggimann
    bluebird bio
  • Great program, great people, great venue.
    Klaus Kühlcke
    EUFETS GmbH
  • Dynamic, interesting and highly interactive event that promotes exchange and networking in highly specialized field of gene therapy.
    Nathalie Clement
    Powell Gene Therapy Center, University of Florida
  • Phacilitate provides a unique forum, bringing together research, process development, and commercial leaders on the cutting edge of cell, gene, and immunotherapy. A great conference for anyone wanting a comprehensive view of the field.
    Dr James Trager
    Dendreon
  • It was all business. I’ve never been to an event where over 80% of the conversations I had were constructive to my business objectives.
    Kurt Gielen
    Chemelot Campus B.V.
  • Great way to expand network with global experts in cell and gene therapy who are facing similar challenges.
    Steven Goodman
    GSK